Rozakis D

NeuroCentrix, Noble Park, Victoria, Australia.

1 paper

ArticleKetamine

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.

Loo C, Glozier N, Barton D +35